National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
IPO Year:
Exchange: NASDAQ
Website: nrchealth.com
| Date | Price Target | Rating | Analyst |
|---|
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
10-Q - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
DEF 14A - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
10-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
National Research Corporation (NASDAQ:NRC), doing business as NRC Health, a publicly-traded leader in healthcare improvement, is pleased to announce the appointment of Trent Green as its incoming Chief Executive Officer, effective June 1, 2025. Green will succeed Mike Hays, the company's current CEO, who will transition to the role of Chairman, ensuring a smooth leadership transition while maintaining NRC Health's mission-driven and shareholder-focused approach. Green brings more than 25 years of healthcare leadership experience, most recently serving as CEO of One Medical, San Francisco, CA, and previously as Chief Operating Officer at Legacy Health, Portland, OR. His expertise in care de
Baron will align and advance NRC Health's experience solutions platform to solve health care industry challenges and continue effectively innovating and supporting experience improvement for health systems across the nation. NRC Health, a recognized leader providing solutions and data driven insights for improving health care experiences, announced today the appointment of Jennifer Baron as the organization's first chief experience officer. Baron's addition is part of the organization's continued investments in leadership and innovation to align with the evolving healthcare landscape. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho
NRC Health, the leading provider of human-centered healthcare solutions and data-driven insights, is elevating its leadership team with the appointment of four executive-officer positions. The strategic move will allow NRC Health to accelerate innovation while continuing to provide exceptional customer experiences to its partners. Four newly created executive leadership roles will guide NRC Health's strategy and success, including: Helen Hrdy, Chief Customer Officer Jason Hahn, Chief Revenue Officer Christophe Louvion, Chief Product Technology Officer Andy Monnich, Chief Corporate Development Officer "Strong leadership is key in driving innovation and meeting the ever-evolv
LINCOLN, Neb., May 19, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, doing business as NRC Health ("NRC Health," "NRC", the "Company), the leading provider of in-depth customer insights in healthcare, today announced the appointment of Parul Bhandari to its Board of Directors, effective immediately. "Along with the rest of the Board, we are excited to share that Parul Bhandari has joined NRC Health as our newest Director," said NRC Health CEO Michael Hays. "Parul is an accomplished technology leader who brings a wealth of expertise on leveraging data and AI for positive impact to her new board role. Her experience driving industry solutions and engaging in digital transformati
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2025 and other corporate developments. Highlights: Total Recurring Value Contract Value Increases Sequentially Sales Force Expansion Accelerates New Share Repurchase Program Announced Operating Expenses Decline Dividend Declared Overview Michael D. Hays, Chief Executive Officer of NRC Health, commented on the Company's performance and recent developments: "The key milestone this quarter was a second consecutive quarter of sequential increase in total recurring contract value, which remains the leading indicator of revenue growth. This progress reflects the rebuilding of o
NRC Health unveils its 2025 Experience Perspective Report, highlighting new research and trends shaping the future of healthcare, with a focus on trust, generational shifts, and evolving consumer demands. NRC Health, a recognized leader in healthcare experience management solutions to transform interactions for patients, consumers, and employees alike, released its 2025 Experience Perspective today during a live national webcast. Known for delivering premier market research and data-driven insights, NRC Health's report features key findings and strategic recommendations based on extensive research involving millions of consumers, patients, and other healthcare leaders nationwide. Guided b
National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 11, 2025, to shareholders of record as of the close of business on Friday, March 28, 2025. For more than 40 years, NRC Health (NASDAQ:NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided by its uniquely empathic heritage, NRC Health's patient-focuse
National Research Corporation (NASDAQ:NRC), doing business as NRC Health, a publicly-traded leader in healthcare improvement, is pleased to announce the appointment of Trent Green as its incoming Chief Executive Officer, effective June 1, 2025. Green will succeed Mike Hays, the company's current CEO, who will transition to the role of Chairman, ensuring a smooth leadership transition while maintaining NRC Health's mission-driven and shareholder-focused approach. Green brings more than 25 years of healthcare leadership experience, most recently serving as CEO of One Medical, San Francisco, CA, and previously as Chief Operating Officer at Legacy Health, Portland, OR. His expertise in care de
UofL Health has selected NRC Health to elevate patient and employee experience across its health system through human-centered healthcare solutions and data-driven insights. This new collaboration aligns with UofL Health's mission to "transform the health of the communities we serve through compassionate, innovative, patient-centered care." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250225833819/en/UofL Health has selected NRC Health to elevate patient and employee experience across its health system through human-centered healthcare solutions and data-driven insights. This new collaboration aligns with UofL Health's mission
NRC Health is proud to partner with UC Health, a relationship designed to support the evolving needs of the patients, consumers, and broader communities UC Health serves. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211543226/en/NRC Health is proud to partner with UC Health, a relationship designed to support the evolving needs of the patients, consumers, and broader communities UC Health serves. UC Health will leverage NRC Health's innovative and trusted Market Insights and Community Insights solutions to truly understand the unique needs, behaviors, and preferences of consumers in today's complex healthcare landscape. (Ph
NRC Health, a leader in advanced technology and data-driven insights to deliver Human Understanding across the healthcare ecosystem, has proudly announced its recognition as the recipient of the esteemed 2025 Best in KLAS Award for Healthcare Experience Management for the second time in three years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250205191488/en/NRC Health, a leader in advanced technology and data-driven insights to deliver Human Understanding across the healthcare ecosystem, has proudly announced its recognition as the recipient of the esteemed 2025 Best in KLAS Award for Healthcare Experience Management for the
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $36.9 million compared with approximately $38.0 million in the 2023 quarter. Earnings per diluted share were $0.28 compared with $0.36 for the 2023 quarter. At December 31, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) was approximately $58.5 million. Total recurring contract value (TRCV) was approximately $133.2 million at December 31, 2024. Dividends and Stock Repurchases During the quarter, the Company returned approximately $10.1 millio
Renown Health has selected NRC Health to enhance its network through human-centered healthcare solutions and next-generation, data-driven insights that deliver Human Understanding to its patients, employees, and the communities it serves. This strategic partnership aligns with Renown Health's mission to "make a genuine difference in the health and well-being of the people and communities we serve." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250107015470/en/Renown Health has selected NRC Health to enhance its network through human-centered healthcare solutions and next-generation, data-driven insights that deliver Human Under
Signature Healthcare has selected NRC Health to enhance its network through human-centered healthcare solutions and next-generation, data-driven insights that deliver Human Understanding to its patients, employees, and communities. This strategic partnership aligns with Signature Healthcare's mission "to be the leading community-based healthcare delivery system in Southeastern Massachusetts, providing the full range of primary care, specialty care, hospital care, and related ancillary services on a coordinated basis." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241120338139/en/Signature Healthcare has selected NRC Health to e
SC 13G/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13G/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13G/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13G/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13G/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2025 and other corporate developments. Highlights: Total Recurring Value Contract Value Increases Sequentially Sales Force Expansion Accelerates New Share Repurchase Program Announced Operating Expenses Decline Dividend Declared Overview Michael D. Hays, Chief Executive Officer of NRC Health, commented on the Company's performance and recent developments: "The key milestone this quarter was a second consecutive quarter of sequential increase in total recurring contract value, which remains the leading indicator of revenue growth. This progress reflects the rebuilding of o
National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 11, 2025, to shareholders of record as of the close of business on Friday, March 28, 2025. For more than 40 years, NRC Health (NASDAQ:NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided by its uniquely empathic heritage, NRC Health's patient-focuse
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $36.9 million compared with approximately $38.0 million in the 2023 quarter. Earnings per diluted share were $0.28 compared with $0.36 for the 2023 quarter. At December 31, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) was approximately $58.5 million. Total recurring contract value (TRCV) was approximately $133.2 million at December 31, 2024. Dividends and Stock Repurchases During the quarter, the Company returned approximately $10.1 millio
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $35.8 million compared with approximately $37.9 million in the 2023 quarter. Earnings per diluted share were $0.24 compared with $0.32 for the 2023 quarter. At September 30, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) was approximately $50.2 million. Total recurring contract value (TRCV) was approximately $131.6 million at September 30, 2024. Dividends and Stock Repurchases During the quarter, the Company returned approximately $11.5 million t
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2024 and several other corporate developments. Financial Results Revenue for the quarter was approximately $35 million compared with approximately $36 million in the 2023 quarter. Earnings per diluted share were $0.26 compared with $0.29 for the 2023 quarter. At June 30, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) was approximately $42 million. Total recurring contract value (TRCV) was approximately $138 million at June 30, 2024. Credit Agreement Amendment Effective August 5, 2024, the Company and its lender entered into a Third Amendm
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2024. CEO Commentary Michael Hays, Chief Executive Officer, commented: "NRC continues to be strongly positioned for growth in our expanding markets. Our decades of benchmarks and trusted thought leadership afford healthcare insights unavailable to most competitors, while our client service remains unmatched, and we continue to roll out innovative new products and technologies. Our mission to enhance outcomes and experiences for everyone in the healthcare journey, while improving our clients' bottom lines, provides true alignment with our clients. "Healthcare systems are facing unp
National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2024 first quarter earnings conference call on Wednesday, May 8, 2024. The Company's results for the 2024 first quarter will be released after the close of the market on Tuesday, May 7, 2024. The live broadcast of National Research Corporation's conference call will begin at 11:00 a.m. Eastern Time on May 8, 2024. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. A live audio webcast can be accessed at https://events.q4inc.com/attendee/554254445. The webcast will also be available for replay. For more than 40 years
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2023. CEO Commentary Michael Hays, Chief Executive Officer, commented: "We're pleased to start 2024 with momentum from another consecutive quarter of growth in new sales and operating margin. We have trimmed non-core service lines, and developed our capability across the patient, customer, and employee experience continuum to focus on our clients' most important needs. With industry-leading solutions – from C-Suite strategy through The Governance Institute, to customized data benchmarking and analysis, to actionable front-line solutions – NRC is better positioned than ever, and our
National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2023 fourth quarter and year-end earnings conference call on Wednesday, February 14, 2024. The Company's results for the 2023 fourth quarter will be released after the close of the market on Tuesday, February 13, 2024. The live broadcast of National Research Corporation's conference call will begin at 11:00 a.m. Eastern Time on February 14, 2024. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. A live audio webcast can be accessed at https://events.q4inc.com/attendee/823574505. The webcast will also be available for
Lincoln, Nebraska, Nov. 17, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, January 12, 2024, to shareholders of record as of the close of business on Friday, December 29, 2023. For more than 40 years, NRC Health (NASDAQ:NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. G
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
3 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)